We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Kiniksa Pharmaceuticals
KNSA
$6.16B
| $4.85M | 0.03% |
323,737
+6,291
| +2% | +$91.6K |
|
402
HealthStream
HSTM
$854M
| $4.8M | 0.03% |
193,353
-2,464
| -1% | -$59.1K |
|
|
RDUS
403
DELISTED
Radius Recycling
RDUS
| $4.8M | 0.03% |
156,558
-67,934
| -30% | -$2.1M |
|
404
Scansource
SCSC
$1.17B
| $4.8M | 0.03% |
164,219
-51,285
| -24% | -$1.52M |
|
|
SNBR
405
DELISTED
Sleep Number
SNBR
| $4.79M | 0.03% |
+184,437
| New | +$5.6M |
|
406
Carlisle Companies
CSL
$13.2B
| $4.77M | 0.03% |
20,235
-471
| -2% | -$121K |
|
407
Oxford Industries
OXM
$579M
| $4.76M | 0.03% |
51,106
-5,284
| -9% | -$529K |
|
408
Extra Space Storage
EXR
$32.7B
| $4.66M | 0.03% |
31,643
-3,785
| -11% | -$605K |
|
409
TriCo Bancshares
TCBK
$1.87B
| $4.65M | 0.03% |
91,187
-4,206
| -4% | -$219K |
|
410
OraSure Technologies
OSUR
$272M
| $4.64M | 0.03% |
963,220
-32,972
| -3% | -$151K |
|
411
The Mosaic Company
MOS
$7.19B
| $4.59M | 0.03% |
104,722
+48,461
| +86% | +$2.4M |
|
412
Genworth Financial
GNW
$3.85B
| $4.57M | 0.03% |
864,413
-1,473,154
| -63% | -$6.93M |
|
|
CCRN
413
DELISTED
Cross Country Healthcare
CCRN
| $4.56M | 0.03% |
171,492
+4,392
| +3% | +$143K |
|
414
Modine Manufacturing
MOD
$9.85B
| $4.51M | 0.03% |
227,239
-42,669
| -16% | -$792K |
|
415
DigitalBridge
DBRG
$2.93B
| $4.48M | 0.03% |
409,916
-140,110
| -25% | -$1.82M |
|
416
James River Group Holdings
JRVR
$221M
| $4.41M | 0.03% |
211,079
+78,565
| +59% | +$1.8M |
|
|
SYNH
417
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.41M | 0.03% |
120,280
+21,324
| +22% | +$843K |
|
418
Kinsale Capital Group
KNSL
$8.58B
| $4.4M | 0.03% |
16,806
+8,916
| +113% | +$2.57M |
|
419
Perdoceo Education
PRDO
$2.15B
| $4.39M | 0.03% |
315,733
-572,044
| -64% | -$7.29M |
|
420
TG Therapeutics
TGTX
$8.23B
| $4.35M | 0.03% |
367,473
+254,978
| +227% | +$1.85M |
|
421
Berkshire Hathaway Class B
BRK.B
$1.1T
| $4.35M | 0.03% |
14,069
+7,692
| +121% | +$2.28M |
|
422
Portland General Electric
POR
$5.85B
| $4.32M | 0.03% |
88,125
-131,093
| -60% | -$6.07M |
|
423
C4 Therapeutics
CCCC
$393M
| $4.3M | 0.03% |
728,671
-10,322
| -1% | -$85.6K |
|
424
OneSpan
OSPN
$586M
| $4.26M | 0.03% |
380,955
-10,483
| -3% | -$120K |
|
425
Encore Capital Group
ECPG
$2.05B
| $4.26M | 0.03% |
88,863
-116,049
| -57% | -$5.6M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.